ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,040.53
-0.50%
US Tech 100
20,778.00
-0.69%
다우존스 지수
44,544.66
-0.75%
Bitcoin
102,179.09
-0.23%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Corcept Therapeutics Inc (0I3Q) 시세

Corcept Therapeutics Inc

Corcept Therapeutics Inc (0I3Q)

LSE
18.23
0.00
(0.00%)
마감 02 2월 1:30AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
18.23
매수가
0.00
매도가
0.00
거래량
1,795
0.00 일간 변동폭 0.00
18.23 52주 범위 18.23
market_cap
1.879B
전일 종가
18.23
개장가
-
최근 거래 시간
8
@
66.44
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
3,289
발행 주식
103,081,000
배당수익률
-
주가수익률
65.07
주당순이익(EPS)
1.03
매출
482.38M
순이익
106.14M

Corcept Therapeutics Inc 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.corcept.com
본부
Wilmington, Delaware, USA
설립됨
-
Corcept Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 런던증권거래소 with ticker 0I3Q. The last closing price for Corcept Therapeutics was US$18.23. Over the last year, Corcept Therapeutics shares have traded in a share price range of US$ 18.23 to US$ 18.23.

Corcept Therapeutics currently has 103,081,000 shares in issue. The market capitalisation of Corcept Therapeutics is US$1.88 billion. Corcept Therapeutics has a price to earnings ratio (PE ratio) of 65.07.

0I3Q 최신 뉴스

추가 뉴스
No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10018.2318.2318.2349618.23DE
40018.2318.2318.2348618.23DE
120018.2318.2318.23328918.23DE
260018.2318.2318.23175518.23DE
520018.2318.2318.23120618.23DE
1560018.2318.2318.2360118.23DE
2600018.2318.2318.2373018.23DE

0I3Q - Frequently Asked Questions (FAQ)

What is the current Corcept Therapeutics share price?
The current share price of Corcept Therapeutics is US$ 18.23
How many Corcept Therapeutics shares are in issue?
Corcept Therapeutics has 103,081,000 shares in issue
What is the market cap of Corcept Therapeutics?
The market capitalisation of Corcept Therapeutics is USD 1.88B
What is the 1 year trading range for Corcept Therapeutics share price?
Corcept Therapeutics has traded in the range of US$ 18.23 to US$ 18.23 during the past year
What is the PE ratio of Corcept Therapeutics?
The price to earnings ratio of Corcept Therapeutics is 65.07
What is the cash to sales ratio of Corcept Therapeutics?
The cash to sales ratio of Corcept Therapeutics is 14.32
What is the reporting currency for Corcept Therapeutics?
Corcept Therapeutics reports financial results in USD
What is the latest annual turnover for Corcept Therapeutics?
The latest annual turnover of Corcept Therapeutics is USD 482.38M
What is the latest annual profit for Corcept Therapeutics?
The latest annual profit of Corcept Therapeutics is USD 106.14M
What is the registered address of Corcept Therapeutics?
The registered address for Corcept Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Corcept Therapeutics website address?
The website address for Corcept Therapeutics is www.corcept.com
Which industry sector does Corcept Therapeutics operate in?
Corcept Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AIQAiq Limited
4.00p
(33.33%)
37.88k
INSPInspirit Energy Holdings Plc
0.0036p
(28.57%)
1.43B
ALKAlkemy Capital Investments Plc
175.00p
(27.27%)
176.27k
KNBKanabo Group Plc
1.00p
(25.00%)
461.04k
TCFTheracryf Plc
1.125p
(25.00%)
6.72M
MET1Metals One Plc
0.275p
(-35.29%)
16.2M
PPSProton Motor Power Systems Plc
0.175p
(-22.22%)
848.7k
SYMESupply@me Capital Plc
0.0025p
(-19.35%)
372.49M
CGNRConroy Gold & Natural Resources Plc
2.15p
(-18.87%)
739.53k
ONCOncimmune Holdings Plc
10.40p
(-16.47%)
1.19M
INSPInspirit Energy Holdings Plc
0.0036p
(28.57%)
1.43B
NTVONativo Resources Plc
0.0018p
(-5.26%)
1.41B
MSMNMosman Oil And Gas Limited
0.041p
(10.81%)
1.22B
TRPTower Resources Plc
0.0295p
(0.00%)
691.76M
SYMESupply@me Capital Plc
0.0025p
(-19.35%)
372.49M

토론

전체 피드 보기
Kam8 Kam8 3 시간 전
LP just doesn't accept Settlement and go discovery🤞😆🤞, I don't think MMs want discovery so they might accept big money for settlement. 😆😆
NWBO
manibiotech manibiotech 3 시간 전
Agree
Usual few will pump this anyway 
NWBO
manibiotech manibiotech 3 시간 전
lol 
The ceiling has already been put at 40M shares
So dream on
NWBO
Deportes Deportes 3 시간 전
Gfy is that better?
ENZC
Hicham007 Hicham007 3 시간 전
Painful but nothing new...

I have averaged down my portfolio to 6.6$ down from 9.8 and I have now 140k shares and i am ready to increase it to 200k if the SP continues on  dropping.  By now Iova is my only stock market investment so we can say all In...

I am ready finan
IOVA
jammy32 jammy32 3 시간 전
As soon as Trump the genius mentioned Tariffs on pharmaceuticals, this puppy got sick and dropped seven cents. Not good. Shouldn’t Nasrat tell us what this means for Elite. Are we subject to the tariffs where is the API from. Is this a good thing or bad thing. Does nasrat know. Does he
API
rosemountbomber rosemountbomber 3 시간 전
Sleven am I understanding correctly that the Generics get their API from China and Amarin doesn't?
API
BlazingStocks BlazingStocks 3 시간 전
$ILLR Triller CEO Sean Kim joins Yahoo Finance to discuss the fight for TikTok's market share and the outlook for the creator economy:https://x.com/YahooFinance/status/1885453406485033258?t=ldZluPpc4DCzgBoH3GagOA&s=19
ILLR
barnstormer barnstormer 3 시간 전
OK Zadie, the judge only allowed a lousy 40 million shares. Still, consider the following (quick back of the envelope math)

40,000,000 shares / (2752(avg daily volume) x 252 (avg yearly trading days) = 700,104 avg yearly shares traded
40,000,000 shares / 700,104 = 57.14 years
NWBO
BlazingStocks BlazingStocks 3 시간 전
Thank you for sharing this! 
ILLR
VMLG17 VMLG17 3 시간 전
And they’d be stupid if they didn’t settle. If a jury learns that the MMs have continued spoofing after the lawsuit was filed, then damages could be more than any settlement amount, not to mention criminal charges later.
NWBO
Macod Macod 3 시간 전
CHANGE in outstanding shares. First change in over a year. Should be more shares reflected with next update. Those lucky enough to buy privates be on the lookout for your certs

O/S 526,142,269
Restricted 297,633,160
Unrestricted 228,509,109

Increase of 7,6
MRGE
mascale mascale 3 시간 전
Hiru Prepared: Likely for new JORC, 2025, Canadian standard less likely needed. ERM is noted in Hiru basis reporting. "Resource reporting and compliance: we prepare mineral resource reports in accordance with international reporting standards such as NI 43-101, JORC, and CIM. Our experts ensure t
HIRU
stealofadeal stealofadeal 3 시간 전
$ BLTHD The way this is looking with not much on the offer we are going much higher. We are sitting way under the radar. I saw 12.00 the third market maker down on the ask.
BLTHD
nowwhat2 nowwhat2 3 시간 전
scoop um up right at black swan.
XRPUSD
loophole lawyer loophole lawyer 3 시간 전
The 3 most important letters for GTCH…..P,C,T……Checkmate
GTCH
Preciouslife1 Preciouslife1 3 시간 전
https://www.mlb.com/news/mets-counting-on-trade-deadline-additions
jxyzobrien jxyzobrien 3 시간 전
hope you are well
sounds like your company is doing great
say hi when you can
flipper44 flipper44 3 시간 전
The court’s R&R did conclude and preserve NWBO illegal spoofing claims alleged to have been committed by defendants.
NWBO
x993231 x993231 3 시간 전
He does like to make a mountain out of a mole hill, but that is what he gets paid to do.  I have him and many of his alternate ID's on ignore.  He is good at asking, why, why, why.  

X. Yves is good at doing his thing.  Funny remember when Lebby said if I don't perform by the end of t
LWLG
havnagoodtime havnagoodtime 3 시간 전
So, what is the short interest and the FTD report on DPLS? Thanks in advance.
DPLS
MartinLutherKing MartinLutherKing 3 시간 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
gladeshawk gladeshawk 3 시간 전
AIRI>>>NEWS. Not a penny play but worth a look. HAWK

https://finance.yahoo.com/news/air-industries-group-closes-fiscal-120000021.html
AIRI
MartinLutherKing MartinLutherKing 3 시간 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
vein vein 3 시간 전
Hey Bubb, I see the cfo received shares , but I don't see the CEO s4??? 
CKPT

최근 히스토리

LSE
0I3Q
Corcept Therapeutics
TG
L7C2
Windfall Geotek
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지